https://www.thehindubusinessline.com/companies/generic-versions-of-novo-nordisks-semaglutide-begin-to-flow-priced-50-80-lower-than-the-innovator/article70769849.ece ...
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...
Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...
The simultaneous patent expiry of Ozempic’s active ingredient in China and India on Friday is a watershed moment. Until now, the revolutionary weight-loss drugs have been available largely to people ...
The upcoming expiry of the semaglutide patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the ...
Weeping Peninsula (South Limgrave) - Dungeons, Points of Interest, and Secrets East Liurnia - Dungeons, Points of Interest, and Secrets North Liurnia - Dungeons, Points of Interest, and Secrets West ...
Indian firms such as Ajanta Pharma, Dr Reddy's Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to fulfil domestic demand for weight-loss drugs with more affordable generic ...
Indian pharma majors Sun Pharma, Dr Reddy’s, Glenmark, and Zydus Lifesciences on Saturday announced the launch of their generic versions of semaglutide injections, used for diabetes and weight ...
MUMBAI: Natco Pharma has heralded what could become an intense pricing war in India’s pharmaceutical sector by offering its generic version of semaglutide at 90% cheaper than the original weight-loss ...
Come March 20, when the patent for Semaglutide expires, the Indian market is expected to see the launch of generic drugs from at least seven pharma companies, at costs ranging from one-third to ...
Natco Pharma Ltd. is set to launch the generic version of Ozempic at a price that's 90% cheaper than the original created Novo Nordisk A/S, triggering a price war for weight-loss drugs in India as the ...
A patient walks into a clinic and asks not about diabetes control, but about weight loss drug. He has seen the results online, heard the name of the drug, and now, with prices falling, wants it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results